Equvila Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 138.76%
(FY 2022)
- Profit 138.69%
(FY 2022)
- Ebitda 47.15%
(FY 2022)
- Net Worth 63.06%
(FY 2022)
- Total Assets 27.07%
(FY 2022)
About Equvila Healthcare
The Corporate was formerly known as Equvila Traders Private Limited. The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashutosh Singh, Vishakha Mhatre, and Satyavijay Shingade serve as directors at the Company.
- CIN/LLPIN
U52609MH2017PTC294980
- Company No.
294980
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Equvila Healthcare Private Limited offer?
Equvila Healthcare Private Limited offers a wide range of products and services, including Immunity Boosters, Vitamin C.
Who are the key members and board of directors at Equvila Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyavijay Shingade  | Director | 17-May-2017 | Current |
| Ashutosh Singh | Additional Director | 18-Jan-2020 | Current |
| Vishakha Mhatre | Additional Director | 10-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Equvila Healthcare.
Equvila Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 138.76% increase. The company also saw a substantial improvement in profitability, with a 138.69% increase in profit. The company's net worth Soared by an impressive increase of 63.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Equvila Healthcare?
Unlock access to Equvila Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Equvila Healthcare?
Unlock and access historical data on people associated with Equvila Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Equvila Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Equvila Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.